Vanta Bioscience IPO IPO

Incorporated in 1995, Vanta Bioscience Ltd (VBL) is a preclinical contract research company which offers safety assessment services for clientele from Pharmaceutical, Medical Devices, Nutraceuticals, Feed Additive, Biotech, Agrochemicals, Cosmetics, and Chemical industries.In addition they also provides risk assessment services for evaluating the safety of the Active Pharmaceutical Ingredients (API), excipients, extractable and leachable including pharmaceutical impurities resulting due to manufacturing process or due to degradation of the product. VBL also provides expert services for determination of health based exposure limits (e.g. permitted daily exposure (PDE) or allowable daily exposure (ADE) including occupational exposure limits (OEL) for pharmaceutical manufacturers. Their services include toxicology, batch release tests, biocompatibility studies, chemical safety, and diet formulation. One of the major services of VBL is conducting variety of in vitro (cell, tissue and organisms) and in vivo (animal) toxicology studies for its diverse clients as per various regulatory requirements from across the world. Toxicology is a branch of biology, chemistry, and pharmacology conce

Vanta Bioscience Ltd. AddressNO 02/G/308/G, NO 3/FF/SF/1-20-248 Umajay ComplexRasoolpuraSecunderabadHyderabad, Telangana, 500003+91 40 6657 5454info@vantabio.comVisit Website